Harvey-Jones E, Raghunandan M, Robbez-Masson L, Magraner-Pardo L, et al. Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor resistant advanced breast cancer. Ann Oncol 2024 Jan 18:S0923-7534(24)00010-3. doi: 10.1016/j.annonc.2024.
PMID: 38244928